DG-01

N/A

Report date: 2025/03/04 16:57:50
NME

Base Information

Drug NameDG-01
Drug Alias NameDG01DG-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic peptide chain release factor GTP-binding subunit ERF3A degradersPolyprenal reductase inhibitors
TargetsEukaryotic peptide chain release factor GTP-binding subunit ERF3APolyprenal reductase
Therapy Area/IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSuzhou Degen Biomedical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSuzhou Degen Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A